Technical LLY stock forecast patterns show a cup-and-handle formation forming on the weekly chart. Breakout above $830 could align with biotech sector ETF inflows, adding further upside potential. The recent stock decline of Novo Nordisk ( NYSE:NVO ) has spooked investors, but this article discusses whether Mr. Market's reaction was overdone. While competition and multiple revised forecasts for FY2025 present real challenges, NVO's core business remains. Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. LLY stock forecast suggests continued bullish momentum as Eli Lilly’s pipeline delivers promising Phase 3 results, particularly in obesity and Alzheimer’s treatments. Analysts are raising EPS estimates for FY2024, with consensus now around $12.
